RBC's Helima Croft: There are no indications that OPEC has any appetite for a 'barrel bailout'
Helima Croft, global head of commodity strategy at RBC Capital Markets, and Fred Kempe, president and CEO of Atlantic Council ...
Bank earnings: JPMorgan, Wells Fargo, Goldman Sachs post beats, and Citi swings to a profit
JPMorgan, Wells Fargo, Goldman Sachs and Citi kicked off earnings season on Wednesday with their December-quarter results.
Edison stock turns volatile as growing blame for wildfires lands on the power company
The catastrophic wildfires in Los Angeles County have rocked the stock of Edison International, the parent company of ...
LA blaze damage likely to be largest wildfire insured loss in US history
The Los Angeles wildfires, which have reduced entire neighborhoods to smoldering ruins and left an apocalyptic landscape, ...
APi Group upgraded at RBC Capital on profit margin outlook
APi Group (NYSE:APG) on Tuesday was upgraded to Outperform from a previous investment rating of Sector Perform by analysts at ...
RBC downgrades Anglo and Antofagasta on valuation concerns and market pressures
Investing.com -- RBC Capital Markets has downgraded both Anglo American (JO: AGLJ) plc and Antofagasta (LON: ANTO) plc to ...
The TRADE1d
RBC Capital Markets names new head of European and Asian product, multi-asset agency solutions
RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager ...
Four feature REIT picks from a RBC analyst
RBC Capital Markets analyst Pammi Bir published a look ahead to 2025 for REITs and emphasized four top picks, ...
BBVA Sabadell Bid Tweak Stems From ‘Sloppy’ Draft, RBC Says
A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous ...
Top 30 global stock ideas from RBC Capital Markets analysts
The research team at RBC Capital Markets published their top 30 global stock ideas for 2025, ...
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials
Vertex secures FDA approval for ALYFTREK and expands TRIKAFTA use, advances diabetes and kidney disease therapies, and ...